Before changing the therapy regimen, researchers from the Mayo Clinic and UCSD said physicians should reassess the patient to determine whether the recurring symptoms are a results of Crohn’s disease or perhaps some other condition, such as enteric infection, concomitant IBS or depression.
They also suggest conducting CT or MR enterography before changing the treatment. If employing capsule endoscopy, physicians should be mindful of potential small-bowel obstruction that would require surgery, they said.
Read the news report about reassessing anti-TNF therapy for Crohn’s disease patients.
Read other coverage about GI studies:
– Diet Impacts Occurrence of Inflammatory Bowel Disease
– Johns Hopkins: Pediatric IBD Cases Growing, but Diagnosed Late
– Study: Patients Taking Isotretinoin at Increased Risk of Ulcerative Colitis
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.